Cullinan Therapeutics has a robust T-cell engager pipeline, savvy management, and a strong cash position. Read more on what investors should know about the company.

Energy stocks led this week as OXY, DVN, EQT and EXE earnings highlight production, cash flow and gas demand trends.

PALO ALTO, CA, UNITED STATES, January 28, 2026 /EINPresswire.com/ -- TuxCare, a global innovator in securing open ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Leaked API keys are nothing new, but the scale of the problem in front-end code has been largely a mystery - until now. Intruder's research team built a new secrets detection method and scanned 5 ...